A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
Clinical trial NCT02979522 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02979522
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2020-05-05
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.